It has been demonstrated that UBE2C plays a vital role in regulating the drug resistance of several types of cancers, such as cisplatin resistance in ovarian cancer[6] and masitinib resistance in esophageal cancer[19]. This evidence concerns the gene UBE2C and ovarian cancer.